Javelin Biotech
The AI engine Fit Assessment
BetaJavelin Biotech effectively leverages machine learning and pattern discovery to enhance drug discovery and expand therapeutic options.
Blurb
Javelin Biotech is a predictive drug discovery platform intended to make an enhanced prediction of the performance of drugs in humans.
HQ Location
Woburn (United States)
Founded
2018
Employees
11 - 50
Total funding raised
Not available
Last Funding Event
Pre-Seed, January 1, 2019
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Discovery Optimization
Operator of a predictive drug discovery platform intended to make an enhanced prediction of the performance of drugs in humans. The company's platform brings the human-relevant in-vitro data and computational biology or data analytics to pre-clinical drug discovery teams by accelerating preclinical drug discovery and development by finding human-relevant targets, enabling biopharmaceutical companies to optimize ADME(T) and PD properties which improves drug discovery and approval of the same.